Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.
https://health-union.com/wp-content/uploads/2022/11/DPE-Keynote-Promo-feature.jpeg 560 1428 Felicia Brecher /wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png Felicia Brecher2022-11-30 08:14:192022-11-30 09:07:47Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience
Two health leaders share wins, challenges and opportunities they've faced as patient and caregiver to help pharma improve the chronic condition experience.
https://health-union.com/wp-content/uploads/2022/11/11-07-22-Thought-Leadership.jpg 840 2202 Stephen Wilson /wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png Stephen Wilson2022-11-08 14:52:072023-05-04 09:43:09Understanding Rare Conditions: Support & Connection
Understanding Rare Conditions: Support & Connection
The internet has allowed people living with chronic conditions to find information, connection and support that might not have been readily available.
https://health-union.com/wp-content/uploads/2022/11/Illuminating-Unmet-Patient-Needs-102022.jpg 560 1428 Lina Kirby /wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png Lina Kirby2022-11-07 10:18:242023-03-24 11:04:22Socially Driven Insights Illuminate Real-Time Patient Needs
Socially Driven Insights Illuminate Real-Time Patient Needs
Survey data like Health Union's "In America" socially driven insights add more context and recency for understanding patient needs in real, actionable ways.
https://health-union.com/wp-content/uploads/2022/09/Rare-Diseases-Health-Union-1.jpg 725 1900 Stephen Wilson /wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png Stephen Wilson2022-09-28 14:03:582023-05-04 09:42:42Understanding Rare Conditions: The Quest for Reliable Information
Understanding Rare Conditions: The Quest for Reliable Information
One-third of NMOSD In America respondents said they struggle to find reliable information on neuromyelitis optica spectrum disorder.